Sleeping Bruxism Treatment Market size was over USD 1.30 billion in 2024 and is estimated to reach USD 2.87 billion by the end of 2037, expanding at a CAGR of 6.8% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of sleeping bruxism treatment is evaluated at USD 1.39 billion.
Modern lifestyles, characterized by demanding work schedules, digital connectivity, and societal pressures, have significantly contributed to rising stress and anxiety levels worldwide. These factors are recognized as primary causes of sleeping bruxism, leading to a higher prevalence of the condition. In July 2024, the National Library of Medicine reported that 21% of people worldwide suffer from sleep bruxism, whereas 23% of people suffer from it while awake. Polysomnography was used to estimate the prevalence of sleep bruxism at 43%. Consequently, there is a growing demand for effective treatment options such as behavioral interventions, stress management techniques, and medications. These therapies aim to alleviate bruxism symptoms by addressing its underlying psychological triggers.
Additionally, the increasing prevalence of sleep disorders, such as obstructive sleep apnea, which is frequently fueled the demand for sleeping bruxism treatment market. In February 2024, the National Library of Medicine reported that the prevalence of sleep disorders doubled over ten years, rising from 3 867 975 (7.62%) in 2011 to 7 446 846 (14.41%) in 2020. These conditions often co-exist, creating a need for comprehensive approaches that address both simultaneously. Healthcare providers are prioritizing holistic treatment plans, combining therapies such as dental appliances, continuous positive airway pressure (CPAP) devices, and behavioral interventions, ensuring effective management of both sleep apnea and bruxism for improved patient outcomes.
Growth Drivers
Challenge
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.8% |
|
Base Year Market Size (2024) |
USD 1.30 billion |
|
Forecast Year Market Size (2037) |
USD 2.87 billion |
|
Regional Scope |
|
Product Type (Mouth Guards, NTI-tss and Splints)
By product type, the NTI-tss and Splints segment is estimated to capture around 62.3% sleeping bruxism treatment market share by the end of 2037. The segment’s growth is due to its proven effectiveness in managing teeth grinding and jaw clenching. NTI-tss devices specifically target the trigeminal nerve to reduce muscle tension, while custom-made splints protect teeth from damage. For instance, in June 2021, Glidewell launched NTI-tss Plus and the NTI OmniSplint. These FDA-approved dental supplies can minimize clenching forces by about 70%. These treatments offer non-invasive, comfortable solutions that align with patient preferences, making them increasingly popular and driving the market demand.
Patient Type (Adult, Pediatric)
Based on patient type, the adult segment is anticipated to hold the majority sleeping bruxism treatment market share over the forecast period. The segment is growing due to increasing stress, anxiety, and lifestyle factors, such as long working hours and sleep disorders, prevalent in adult populations. According to a Sleep Foundation article, published in April 2024, bruxing is more common in younger adults who may exert around 250 pounds of pure force while grinding. In addition, 8% of middle-aged and 3% of other adults are estimated to suffer from this condition. As awareness about the harmful effects of untreated bruxism, such as tooth damage and jaw issues, rises, more adults are seeking treatment. The availability of non-invasive solutions, such as mouthguards and biofeedback devices, further contributes to the growth of sleeping bruxism treatment.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Patient Type |
|
|
End User |
|
North America Market Statistics
North America sleeping bruxism treatment market is poised to dominate revenue share of around 39.5% by the end of 2037. Rising cases of sleeping bruxism, often associated with stress, anxiety, and changing lifestyles, are significantly increasing the demand for effective treatment options. Growing awareness about the condition’s potential long-term effects, including tooth damage, jaw disorders, and chronic pain, has prompted more individuals to seek timely medical advice and solutions. Innovative diagnostics and treatments, such as portable sleep monitors, custom mouthguards, and biofeedback devices, ensure accurate detection and effective management.
Stress-related disorders, frequently intensified by hectic work environments, societal pressures, and modern lifestyles, are significant contributors to the rise in bruxism cases. Growing awareness of mental health in the U.S. has prompted more individuals to seek help for stress-induced conditions such as bruxism, leading to increased demand for effective treatment options and solutions. Additionally, wearable devices monitoring jaw activity during sleep revolutionize bruxism management, improving treatment adherence and outcomes, and marking progress in the sleeping bruxism treatment market.
In Canada, patients are showing a growing preference for non-invasive solutions, including custom-made mouthguards, biofeedback devices, and behavioral therapies. These options offer effective management of sleep bruxism without requiring surgical or pharmaceutical interventions, catering to patient demands for safer, more comfortable, and convenient treatment methods, driving the sleeping bruxism treatment market growth. For instance, in April 2021, the acquisition of an exclusive license to register, market, and commercialize a botulinum toxin (DTX-021) in the US and Canada was announced by Aquavit Holdings LLC. Furthermore, emphasis on oral health boosts demand for dental check-ups, early bruxism detection, and customized treatments.
Asia Pacific Market Analysis
The Asia Pacific sleeping bruxism treatment market is established to garner the fastest CAGR over the forecast period. The rising prevalence of sleeping bruxism in the Asia Pacific region, fueled by stress, anxiety, and a fast-paced lifestyle, is a key factor driving market growth. Educational campaigns and increased awareness about the negative effects on oral health and overall well-being are motivating individuals to seek timely diagnosis and effective treatment options. Telehealth platforms in the Asia Pacific enhance access to bruxism treatments, especially in rural areas, driving therapy adoption regionwide.
The rising incidence of sleep disorders, including insomnia and sleep apnea, in China, has heightened awareness of bruxism as a related condition. In August 2023, the National Library of Medicine reported that sleep disorders are found in 8.96 to 49.90% of Chinese people in various locations. As more people seek treatment for sleep issues, there is an increased recognition of bruxism’s role in overall sleep health, driving the demand for targeted therapies and treatment options for bruxism. Modern diagnostic tools, including sleep monitors and imaging technologies, enable early, precise bruxism detection, driving effective treatments and sleeping bruxism treatment market growth.
Rapid urbanization in India is leading to increasingly stressful lifestyles, with long working hours, high expectations, and societal pressures. The combined estimates for the prevalence of insomnia, OSA, and RLS were 25.7%, 37.4%, and 10.6%, respectively, as of December 2023. This rising stress significantly contributes to sleep-related disorders such as bruxism, causing a higher demand for effective treatment options as more individuals seek to manage these conditions. Additionally, the expanding middle class and higher disposable income are driving increased spending on healthcare, boosting the adoption of bruxism treatments in urban areas. Thus, propelling the sleeping bruxism treatment market.
Key companies in the sleeping bruxism treatment market are innovating by developing advanced solutions like custom-made mouthguards, biofeedback devices, and wearable technologies. These innovations enable more effective management by offering personalized treatments, real-time monitoring, and non-invasive options. Companies are also enhancing diagnostic tools, such as portable sleep monitors, to facilitate early detection, driving growth by improving treatment outcomes and patient adherence. These companies are:
Author Credits: Radhika Pawar
Copyright © 2025 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?